Death domain-associated protein (Daxx) cooperates with X-linked a-thalassaemia retardation syndrome protein (ATRX), a putative member of the sucrose non-fermentable 2 family of ATP-dependent chromatin-remodelling proteins, acting as the core ATPase subunit in this complex, whereas Daxx is the targeting factor, leading to histone deacetylase recruitment, H3.3 deposition and transcriptional repression of cellular promoters. Despite recent findings on the fundamental importance of chromatin modification in host-cell gene regulation, it remains unclear whether adenovirus type 5 (Ad5) transcription is regulated by cellular chromatin remodelling to allow efficient virus gene expression. Here, we focus on the repressive role of the Daxx/ATRX complex during Ad5 replication, which depends on intact protein-protein interaction, as negative regulation could be relieved with a Daxx mutant that is unable to interact with ATRX. To ensure efficient viral replication, Ad5 E1B-55K protein inhibits Daxx and targets ATRX for proteasomal degradation in cooperation with early region 4 open reading frame protein 6 and cellular components of a cullindependent E3-ubiquitin ligase. Our studies illustrate the importance and diversity of viral factors antagonizing Daxx/ATRX-mediated repression of viral gene expression and shed new light on the modulation of cellular chromatin remodelling factors by Ad5. We show for the first time that cellular Daxx/ATRX chromatin remodelling complexes play essential roles in Ad gene expression and illustrate the importance of early viral proteins to counteract cellular chromatin remodelling.
INTRODUCTION
For >50 years, adenovirus biology has mainly focused on virus/host interactions and has established that manipulation of host cell homeostasis is required for efficient infection. Despite recent findings on the fundamental importance of chromatin status in host-cell gene regulation, it remains unclear whether adenovirus (Ad) transcription is subject to cellular chromatin remodelling. Recent reports demonstrated that Ad DNA is present in a tightly condensed state in the nucleocapsid, arguing for the requirement of altering chromatin modification early in infection to allow efficient virus gene expression.
We and others reported previously that the transcriptional repressor 'death domain-associated protein' (Daxx) is a principal component of 'promyelocytic leukemia protein (PML) nuclear bodies' (PML-NBs) and a negative regulator of Ad5 replication during productive infection (1, 2) . Daxx is mainly found in the nucleus, associated to PML-NBs, or at heterochromatin areas in a complex with 'X-linked a-thalassaemia retardation syndrome protein' (ATRX) (3) (4) (5) . PML-NB association of Daxx was found to alleviate gene repression and activate apoptosis, whereas chromatin-bound Daxx acts in a transcriptionally repressive manner [summarized in Figure 10A ; (6) (7) (8) ]. Daxx association to either PML-NBs or chromatin depends on the status of the host cell and on the interaction of Daxx with other nuclear proteins (e.g. PML, ATRX), which can be regulated by post-translational modifications. Recently, Ishov et al. (9) observed that cell cycle dependent phosphorylation regulates the exit of Daxx from PML-NBs prior to assembly to ATRX and chromatin associated proteins like histone deacetylases, acetylated histone H4 and Dek at condensed chromatin regions (10) .
So far, the mechanisms of negative transcriptional regulation by Daxx remain only poorly understood, although Daxx association with repressive chromatin remodelling complexes has been proposed [summarized in Figure 10B ; (10, 11) ]. Recently, it was shown that Daxx interacts with ATRX, a large protein of 280 kDa containing a putative ATPase/helicase domain, homologous to members of the 'Switch/Sucrose non-fermentable' (SWI/ SNF) family of chromatin remodelling proteins (9, 12, 13) . In addition, ATRX contains a 'plant homeodomain', similar to the DNA methyltransferase 3 family of proteins (14, 15) . Daxx interacts with ATRX through its NH2-terminal PAH1 domain ('paired amphipathic alpha helix') (9, 12, 13) . Furthermore, Daxx recruits ATRX to the PML-NBs and interferes with ATRX-mediated transcriptional repression [summarized in Figure 10A ; (9) ]. These results suggest that Daxx regulates ATRX activity by altering its localization in the nucleus. The association between ATRX and PML-NBs also supports the observation that these nuclear bodies regulate diverse cellular processes by modulating transcription.
Others reported that Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replicationindependent chromatin assembly at telomeres (16) . Moreover, ATRX and H3.3 play essential roles in maintaining telomere chromatin (17, 18) . Further insight into H3.3-specific deposition pathways was gained by identifying the highly conserved N terminus of Daxx as the direct binding partner of H3.3. It was shown that recombinant Daxx assembles H3.3/H4 tetramers on DNA templates, and that deposition and remodelling of H3.3-containing nucleosomes is catalysed by the Daxx/ATRX complex (19) . Although originally associated with euchromatic sites of active transcription, H3.3 has recently been found associated with regulatory elements and constitutive heterochromatin (20) (21) (22) . In summary, Daxx alone or in a complex with ATRX was observed to most presumably repress transcription by effectively assembling H3.3-containing nucleosomes (16) .
Ad are non-enveloped viruses with an icosahedral capsid and linear double-stranded DNA (23) . The viral genome includes transcription units encoding $40 regulatory and structural proteins, and usually two non-coding RNAs ('virus-associated RNAs'), depending on the serotype. Ad5 proteins are derived from early (E1A, E1B, E2A, E2B, E3 and E4) or late (L1-L5) transcription units. The E1A region is the first transcription unit activated following Ad5 infection (24, 25) . Mechanistically, E1A proteins stimulate the infected cell to enter S phase and are required to promote the transcription of other early viral genes (26) (27) (28) . The function of the early region E1B-55K protein is more diverse. As a multifunctional phosphoprotein, it promotes efficient viral replication via a number of different mechanisms. In the early phase of productive Ad5 infection, E1B gene products counteract anti-proliferative processes induced by the host cell (29) (30) (31) . Additionally, E1B-55K controls efficient late viral protein production by stimulating preferential cytoplasmic accumulation and translation of viral late mRNAs during the late phase of infection (32, 33) . Multiple functions of E1B-55K require interaction with viral 'early region 4 open reading frame protein 6' (E4orf6). Together, both proteins assemble a Skp, Cullin, F-box (SCF)-like E3-ubiquitin ligase complex, initiating proteasomal degradation of cellular targets such as p53, Mre11, DNA ligase IV, integrin a3 subunit and Bloom-helicase (34) (35) (36) (37) (38) . In contrast, we recently discovered that E1B-55K antagonizes the innate antiviral activities of Daxx by targeting the cellular protein for E4orf6-independent proteasomal degradation (1) .
Here, we demonstrate that in addition to Daxx, the nuclear, chromatin remodelling factor ATRX represses Ad5 replication in infected human cells. We observed significantly enhanced viral gene expression after limiting functional Daxx/ATRX chromatin remodelling complexes in the nucleus. These data provide evidence that chromatin modulating proteins play a major role in a host cell intrinsic defense mechanism against adenoviruses. We observed that ATRX protein concentrations are antagonized by proteasomal degradation via the E1B-55K/E4orf6 E3 ubiquitin ligase complex during Ad5 productive infection. Our findings affect future studies on Ad chromatinization and influence further research areas. As Ad-based vectors are frequently used in gene therapy, understanding viral gene expression within the host improves vector efficacy. Considering the fundamental importance of chromatin formation in host-cell gene regulation, investigating whether Ad transcription is regulated by cellular chromatin remodelling will contribute to the identification of new therapeutic targets to limit or prevent virus-mediated diseases and mortality of infected patients.
MATERIALS AND METHODS

Cell culture
Hep reDaxx and Hep Daxx PAH were established using parental lentivirus vector pLKO-shDaxx2 (39) and inserting yellow fluorescent protein (EYFP)-Daxx and EYFPhDaxx_PAH1 (39) . For the Daxx/ATRX knockdown, we constructed a lentivirus for double depletion of Daxx and ATRX (pLKO-shDaxx/ATRX) by replacing the shPML-siRNA sequence with a short hairpin RNA against ATRX (5 0 -CGACAGAAACTAACCCTGTAA-3 0 ) (40) in a lentivirus designed for simultanous depletion of Daxx and PML (41) . A scrambled shRNA-expressing lentivirus was used as negative control. Lentivirus supernatants were prepared by co-transfection of HEK293T cells with the respective pLKO vector, pVSV-G (expressing the vesicular stomatitis virus (VSV) envelope protein) and pCMV.DR8.91 (expressing lentivirus helper functions), as described previously (42) . Stable cell lines were selected using puromycin (initially 1 mg/ml and then reduced to 0.5 mg/ml during subsequent passage). H1299 Cullin-5 negative cells and the H1299 control cell line were described previously (37, 43) . Daxx-depleted U2OS cells (U2OS+shDaxx) were generated by transduction of lentivirus vectors expressing shRNA targeted to the coding strand sequence 5 0 -GGAGTTGGATCTCTCAGAA-3 0 located at nt 626-643 in Daxx (44) . HepaRG cell lines (1, 39, 45) , HEK293 cells (46) , p53 negative human cell line H1299 (47) and osteosarcoma cell line U2OS (48) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 U of penicillin and 100 mg of streptomycin per millilitre in a 5% CO 2 atmosphere at 37 C. For HepaRG cells, the media was supplemented with 5 mg/ml of bovine insulin and 0.5 mM of hydrocortisone.
Plasmids, mutagenesis and transient transfections
Ad5 proteins examined in this study were expressed from their respective complementary DNA under the control of the cytomegalo virus (CMV) immediate early promoter, derived from pcDNA3 vector (Invitrogen), to express E1B-55K and E4orf6 (49, 50) . Luciferase reporter constructs were generated by cloning polymerase chain reaction (PCR)-amplified Ad promoter constructs upstream of the promoterless firefly luciferase gene in the pGl3-basic vector (Promega). The respective Ad promoters were amplified from CAT vectors (kindly provided by Shenk) with specific oligonucleotides, introducing a XhoI/ HindIII restriction site (see Table1) . For transient transfections, cells were treated as described previously (1) . Plasmid pEGFP-ATRX (51) was a kind gift from Picketts.
Viruses
H5pg4100 served as the wild-type Ad5 parental virus in this study (52) . The mutant viruses H5pm4149 and H5pm4154 were generated as described recently (53) . Both viruses carry stop codons in the E1B-55K (H5pm4149) or E4orf6 (H5pm4154) open reading frames and do not express the respective viral protein (54) . The H5pm4139 was generated carrying amino acid changes in the (elongins B and C) BC1 and BC2 box motifs of E4orf6 resulting in a drastically reduced ability to associate with the Ad5 E3 ubiquitin ligase complex compared with the E4orf6 protein from wild-type virus (53) . Viruses were propagated and titrated in HEK293 monolayer cultures. Infections were performed as described previously (55) . To measure virus growth, infected cells were harvested 24, 48 and 72 h post-infection and lysed by three cycles of freeze thaw. The cell lysates were serially diluted in Dulbecco's modified Eagle's medium for infection of HEK293 cells, and virus yield was determined by quantitative E2A-72K immunofluorescence staining 24 h after infection (52) . Viral DNA replication was monitored by quantitative PCR using E1B-specific primers (E1B-fwd 3 0 -CGCGGG ATCCATGGAGCGAAGAAACCCATCTGAGC-5 0 ; E1B-rev 3 0 -CGGTGTCTGGTCATTAA GC TAAAA-5 0 ) exactly as described previously (50) . PCR products were analysed on a 1% agarose gel and quantified using the G-Box system and Gene-Tools software (Syngene).
Amount of viral particles was monitored by quantitative PCR. HepaRG cells were infected with wild-type virus H5pg4100, harvested at 48 h post-infection (h. p. i.), total cell extracts were prepared and treated with proteinase K. Quantitative real-time PCR was performed using hexon-specific primers (hexon-qPCR-fw: 5 0 -CGCT GGA CATGACTTTTGAG-3 0 ; hexon-qPCR-rev: 5 0 -GAACGG TGTGCGCAGGTA-3 0 ). Ad5 H5pg4100 bacmid DNA was used as a control to obtain a standard curve.
Quantitative real-time PCR analysis
Subconfluent cells were infected with wild-type virus and harvested at 48 h. p. i. Total RNA was isolated with 'Trizol reagent' (Invitrogen) as described by the manufacturer. The amount of total RNA was measured, and one microgram of RNA was reverse transcribed using the 'Transcriptor High Fidelity cDNA Synthesis Sample Kit' from Roche including anchored-oligo(dT) 18 primer specific to the poly(A) + RNA. Quantitative real-time (qRT) PCR was performed with a first strand method in a Rotor-Gene 6000 (Corbett Life Sciences, Sydney, Australia) in 0.5 ml of reaction tubes containing a 1/100 dilution of the cDNA template, 10 pmol/ml of each synthetic oligonucleotide primer, 12.5 ml/sample 'Power SYBR Green PCR Master Mix' (Applied Biosystems). The PCR conditions were as follows: 10 min at 95 C, 55 cycles of 30 s at 95 C, 30 s at 55 C-62 C (depending on the primer set) and 30 s at 72 C. The average C t value was determined from triplicate reactions, and levels of viral mRNA relative to cellular 18S rRNA were calculated as described recently (56) . The identities of the products obtained were confirmed by melting curve analysis.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assay (ChIP) analysis was performed as described previously with some modifications (57, 58) . Proteins were cross-linked to DNA with 1% formaldehyde in phosphate buffered saline for 10 min at RT. The reaction was quenched, cells were washed with phosphate buffered saline and harvested by scraping off the dish. Nuclei were isolated by incubating cross-linked cells with 500 ml of buffer I [50 mM Hepes-KOH, 140 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 10% glycerol, 0.5% NP-40, 0.25% Triton X-100] for 10 min on ice and pelleted by centrifugation. Nuclei were subsequently washed with 500 ml of buffer II (10 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 0.5 mM (EGTA) ethylene glycol tetraacetic acid), pelleted again and resuspended in 500 ml of buffer III [1% sodium dodecyl sulphate (SDS), 10 mM EDTA, 50 mM Tris-HCl]. Chromatin was fragmented by sonication using a BioruptorTM (Diagenode) to an average length of 100-300 bp. After addition of 10% Triton X-100, cell debris was pelleted by centrifugation and supernatants were collected. Chromatin was diluted with buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, 167 mM NaCl). To reduce non-specific background, chromatin was pre-incubated with salmon-sperm DNA protein-A agarose beads (Upstate). Antibodies (Ab) were added and incubated for 16 h at 4 C. The 50 ml of agarose beads were added to precipitate the chromatin immunocomplexes for 4 h at 4 C. Beads were washed once with low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, 150 mM NaCl), once with high-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, 500 mM NaCl), once with LiCl-wash buffer (0.25 M LiCl, 1% Nonidet P-40, 1% Na-deoxycholate, 1 mM EDTA, 10 mM TrisHCl) and twice with TE buffer. Chromatin was eluted from the beads in elution-buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% SDS) for 10 min at 95 C. ProteinaseK was added for protein degradation, and samples were incubated for 1 h at 55 C. To prepare input controls, samples were treated like IP samples except that non-specific Abs were used. qRT PCR analysis was performed using a Rotor Gene 6000 (Corbett Life Sciences) in 0.5 ml of reaction tubes containing 1/100 dilution of the precipitated chromatin, 10 pmol/ml of each synthetic oligonucleotide primer (see Table 2 ), 5 ml/sample SYBR Green PCR Master Mix (Applied Biosystems). The PCR conditions used: 7 min at 95 C, 45 cycles of 12 s at 95 C, 40 s at 60 C and 15 s at 72 C. The average C t -value was determined from triplicate reactions and normalized against non-specific immunoglobulin G (IgG) controls (sc-2027; Santa Cruz Biotechnology) with standard curves for each primer pair. The identities of the products obtained were confirmed by melting curve analysis.
Luciferase reporter assays
For dual luciferase assays, subconfluent cells were transfected as described previously (55, 59 ), using 0.5 mg of reporter and 0.5 mg of pRL-TK (Promega), which expresses Renilla luciferase under the control of the herpes simplex virus thymidine kinase promoter. As described by the manufacturer (Promega) for dual luciferase assays, total cell extracts were prepared 48 h after transfection, and retinal ganglion cells (RGC) firefly luciferase activity was assayed with 5 ml of lysed extract in an automated luminometer (Berthold Technologies). All samples were normalized for transfection efficiency by measuring Renilla luciferase activity. All experiments shown were performed as triplicates, and data are presented as mean values.
Micrococcal nuclease nuclease accesibility assay
Cell pellets were lysed in a hypotonic buffer (10 mM TrisHCl (pH 7.4), 10 mM KCl, 15 mM MgCl 2 ) on ice for 10 min. Nuclei were pelleted by centrifugation and C for varying periods. The MNase reaction was stopped by the addition of 10 mM EDTA followed by centrifugation. The pellet was then resuspensed in MNase digestion buffer supplemented with 10 mM EDTA and RNase and incubated at 37 C for 30 min. The DNA was extracted and purified by standard procedures. Digested chromatin was analysed on a 1.4% agarose gel using the G-Box system and Gene-Tools software (Syngene). Band intensities were quantified with ImageJ and analysed with GraphPad Prism software.
Protein analysis and Ab
Cells were resuspended in radioimmunoprecipitation buffer (RIPA) buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA, 1 mM dithiothreitol (DTT), 0.1% SDS, 1% NP-40, 0.1% Triton X-100, 0.5% sodium deoxycholate) containing 1% (v/v) PMSF, 0.1% (v/v) aprotinin, 1 mg/ml of leupeptin, 1 mg/ml of pepstatin, 1 mM DTT, 25 mM iodacetamide and 25 mM N-ethylmaleimide. After 1 h on ice, the lysates were sonicated, and insoluble debris was pelleted at 15 000Âg/ 4 C. Fractionation of soluble and chromatin-rich fractions was reported recently (60) . For immunoprecipitation and immunoblotting, protein lysates were treated as described recently (61) . Primary Ab specific for Ad proteins used in this study included E1A mouse monoclonal antibody (MAb) M73 (62), E1B-55K mouse MAb 2A6 (63), E2A-72K mouse MAb B6-8 (64), E4orf6 MAb RSA3 (65) and Ad5 rabbit polyclonal serum L133 (66) . Primary Ab specific for cellular proteins included ATRX rabbit Ab H-300 (Santa Cruz Biotechnology), ATRX mouse MAb clone 39F (kindly provided by Gibbons), Daxx rabbit polyclonal Ab 07-471 (Upstate/ Millipore), anti-histone H3.3 rabbit polyclonal Ab ab62642 (Abcam), PML rabbit poyclonal Ab H-238 (Novus Biologicals) and ß-actin mouse MAb AC-15 (Sigma-Aldrich). EYFP epitopes were detected with anti-green fluorescent protein (GFP) rabbit Ab ab290 (Abcam). Secondary Ab conjugated to horseradish peroxidase to detect proteins by immunoblotting were anti-rabbit IgG and anti-mouse IgG (Jackson/Dianova).
RESULTS
Efficient Ad5 replication is restricted by Daxx and ATRX
Ad5 replication centres establish in the vicinity of nuclear PML-NBs, as demonstrated by recruitment of viral and host proteins required for DNA replication, transcription and gene expression to these nuclear foci (67) . We previously showed that the transcriptional repressor and PML-NB resident factor Daxx suppresses Ad5 replication early in infection (1) . Daxx is linked to transcriptional repression via interaction with ATRX in a functional, ATP-dependent, SWI/SNF chromatin remodelling complex, recruiting histone deacetylase (HDACs) to sites Figure 1A ; (1) Figure S1A ). Therefore, we are tempted to speculate that efficient Ad gene expression requires Daxx/ATRX elimination during infection or at least limitation of the protein concentrations to counteract the repressive activity determined by both transcription factors. We further determined quantitative PCR analysis to precisely quantify virus concentration using hexon-specific primers (Supplementary Figure  S1B) . We observed reduced amount of Ad5 viral DNA copies in cells depleted for Daxx and/or ATRX (Hep shDaxx, Hep shATRX, Hep shDaxx/shATRX; Figure 3A) .
Compared with parental control cells and cells expressing an EYFP-Daxx fusion protein [Hep reDaxx; (1)], the absence of either Daxx and/or ATRX stimulated $5-fold expression from E1A and E1B promoters, $8-fold from the E2 early promoter and $4-fold from the MLP promoter ( Figure 3A) .
As Daxx contains no DNA binding region, it is supposed that ATRX is the molecular bridge connecting the complex to chromatin. To show direct association of ATRX with adenovirus promoters, we performed ChIP in virus-infected HepaRG cells, using ATRX Ab, unrelated IgG control Ab and Ad promoter-specific primers (Table 2; Figure 3B ). The results show that ATRX is associated with Ad promoters in infected Hep parental cells 24 h after infection ( Figure 3B) . To support the model that ATRX recruits Daxx to Ad promoters, we inclued Hep shATRX cells to our ChIP analysis. As anticipated, we did not observe ATRX chromatin binding to Ad promoter sequences in the shATRX cells, excluding unspecific background of the ATRX-specific Ab. To further elucidate whether ATRX bound to adenoviral promoters is Daxx independent, we carried out additional ChIP experiments in Daxx-depleted (Hep shDaxx) cells and in cells without a functional Daxx/ATRX complex (Hep Daxx PAH). We observe that ATRX is targeted to Ad5 promoters independent of Daxx, as we were still able to detect ATRX recruitment ( Figure 3B ). Conclusively, we clarified the interdependence of Daxx and ATRX when targeting viral promoters illustrating an ATRX-dependet process, independent of the complex formation with Daxx. Taken together, these results indicate that ATRX relocalizes Daxx to Ad promoter regions, and that both transcription factors mediate repression of Ad5 productive replication.
ATRX expression in ATRX knockout cells is sufficient to repress Ad5 gene expression
Next, we analysed Ad5 replication in U2OS cells, which lack ATRX protein expression ( Figure 4A; 39,64,68) . First, we monitored Daxx protein levels and observed significant reduction in the presence of wild-type virus ( Figure 4A ). Consistent with our observations in infected HepaRG cells (Supplementary Figure S1A) , Daxx was still degraded in the absence of ATRX. This result confirms that fact that inhibition of both repressors might occur via independent mechanisms. Next, we tested whether Daxx depletion ( Figure 4A ) affects adenovirus production and gene expression in U2OS cells. We observed no effect on adenovirus progeny production in the absence of Daxx (U2OS+shDaxx; Figure 4B ). When ATRX was provided in trans, expressed from a pEGFP construct with 41% efficiency of transfection (data not shown), virus growth was 3-fold less than in control cells, where Ad5 was not repressed ( Figure 4B ). The same result was obtained when we quantified the amount of viral DNA copies ( Figure 4C ) and viral DNA synthesis. (Figure 4D ). Taken together, Figure 4 . Daxx/ATRX functional complex modulates productive Ad replication. U2OS cells were transfected with either empty vector or pEGFP-ATRX plasmid expressing human ATRX 24 h before infection with wild-type H5pg4100 virus or E1B-55K minus virus mutant H5pm4149 at moi of 50 FFU per cell. (A) U2OS cells were harvested at 48 h. p. i., total cell extracts were prepared and proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and subjected to immunoblotting using mouse ATRX-specific mouse Mab or Daxx-specific rabbit Ab. Corresponding b-actin was included as a loading control. (B) Viral particles were harvested 24, 48 and 72 h. p. i., and virus yield was determined by quantitative E2A-72K immunofluorescence staining on HEK293 cells. Averages from three independent experiments are shown. Error bars indicate the standard error of the mean. (C) U2OS cells were harvested at 48 h. p. i., total cell extracts were prepared and treated with proteinase K. Quantitative real-time PCR was performed using hexon-specific primers. Ad5 H5pg4100 bacmid was used to obtain a standard curve. The results represent the averages from three independent experiments. Error bars indicate the standard error of the mean. (D) Total cell extracts were prepared and treated with proteinase K. PCR was performed and identicle amounts of PCR product were separated on an analytic agarose gels (1%) and quantified with Gene Snap Software (Syngene). depletion of Daxx in U2OS cells, lacking ATRX gene expression, did not show supportive effects on adenovirus gene repression. Moreover, as with HepaRG cells ( Figure  1B; Supplementary Figure S1B) , amount of Ad5 DNA copies ( Figure 4C ) and viral DNA synthesis ( Figure 4D ) was reduced in U2OS cells when transfected with the ATRX-encoding construct before infection. We note that induction of Ad5 gene expression is more pronounced in ATRX knockout (U2OS) than ATRX knockdown (Hep shATRX) cells, likely owing to diverging ATRX concentrations. Next, we tested expression of viral early E1A, E1B-55K, E4orf6 and late proteins (Supplementary Figure S3) at different time points after Ad5 wild-type infection in the different U2OS cells. Expression of all viral proteins monitored was substantially reduced in cells expressing ATRX in trans (Supplementary Figure S3 , lanes 7-9). Consistent with this observation, we showed no efficient mRNA synthesis in infected U2OS cells stably expressing the ATRX transcription factor ( Figure 5 ; U2OS +EGFP-ATRX) in comparison with various control cells (U2OS control, U2OS+EGFP-empty, U2OS+shDaxx). These results indicate that both PML-NB components, Daxx and ATRX, are negative regulators of Ad5 productive replication.
ATRX protein levels are reduced during lytic Ad infection in human cells
So far, various reports clearly demonstrate that Ad disrupts PML-NBs in the early phase of infection via relocalization into track-like structures. Our findings show that the Daxx/ATRX complex can repress transcription independent of PML-NB association. Therefore, Ad-mediated track-like formation is most likely not interfering with Daxx/ATRX repressive attributes. Consequently, we proposed that efficient Ad gene expression requires Daxx/ATRX inhibition during infection or at least limitation of repressive activity by post-translational modifications. We therefore monitored ATRX protein levels in Ad-infected cells and observed that ATRX concentrations are reduced during wild-type (wt) (H5pg4100) lytic infection ( Figure 6A ). In contrast, we observed no ATRX reduction in infected cells lacking either E1B-55K (H5pm4149) or E4orf6 (H5pm4154; Figure 6A ). E1B-55K is likely the substrate recognition unit, whereas E4orf6 assembles the cellular components into Ad5 dependent E3 ubiquitin ligase. To determine whether ATRX is a novel binding partner of E1B-55K, we performed binding assays in Ad5 wild-type (H5pg4100), E1B-55K (H5pm4149) and E4orf6 (H5pm4154) mutant virus-infected cells lacking the respective viral protein. Co-immunoprecipitation of E1B-55K with ATRX-specific MAb revealed an interaction between both factors during lytic Ad5 infection ( Figure 6A, lanes 2 and 4) , whereas no signal was detected in the corresponding controls ( Figure 6A, lanes  1 and 3) . We detected nearly identical amounts of -MG 132 + MG 132 Figure 6 . Proteasomal degradation of ATRX in infected and transfected cells. H1299 cells were infected with wild-type (H5pg4100) and mutant viruses (H5pm4149, H5pm4154) at moi of 50 FFU per cell. (A) Total cell extracts were prepared 48 h. p. i., and proteins were separated by SDS-PAGE and subjected to immunoblotting using mouse MAb 2A6 (E1B-55K), mouse MAb RSA3 (E4orf6), Daxx specific rabbit Ab and ATRX-specific mouse MAb clone 39F. b-actin was included as a loading control. Co-immunoprecipitation (IP) of E1B-55K was performed with ATRX-specific mouse MAb clone 39F followed detection of co-precipitated E1B-55K with mouse MAb 2A6. (B) Infected cells (as aforementioned) were treated for 6 h with proteasome inhibitor (+MG 132), before total cell extracts were prepared and specific proteins detected as described in A.
(C) H1299 cells were transfected with pcDNA3-derived plasmids expressing wild-type E1B-55K, E4orf6 or a combination of both. Cells were harvested 48 h. p. i. Total cell extracts were prepared, and specific proteins were immunoprcipitated and detected as described in (A).
co-precipitated E1B-55K protein, although the ATRX input levels were greatly altered, dependent on proteasomal degradation. This might be due to limiting conditions of Ab-coupled protein A-sepharose in these IP experiments, which ensures complete saturation of the beads with ATRX Ab. To control coimmunoprecipitation of E1B-55K with ATRX-specific MAb, we repeated the experiment in the Hep shATRX cells in the absence of ATRX and did not observe any non-specific band (data not shown). The decrease in ATRX seen in wild-type infected cells was abolished when we treated the cells with proteasome inhibitor MG 132 ( Figure 6B, lanes 2 and 6 ). These data demonstrate that in contrast to E1B-55K-dependent degradation of Daxx (1), ATRX is targeted via a proteasomal pathway, which requires E1B-55K in cooperation with E4orf6. To test our hypothesis, we first analysed the levels of ATRX protein in plasmid-transfected cells in the absence of a viral background ( Figure 6C ). Expression of wild-type E1B-55K or E4orf6 alone had no effect on endogenous ATRX protein concentrations ( Figure 9C, lanes 2 and 3) , whereas expression of both ( Figure 6C , lane 4) diminished ATRX protein levels similarly to wild-type-infected cells ( Figure 6A, lane 2) .
ATRX protein is degraded via an Ad5 E1B-55K/E4orf6-dependent E3 ubiquitin ligase complex
Ad5 E1B-55K and E4orf6 assemble an E3 ubiquitin ligase complex containing the Cullin family member Cullin5, Elongins B and C, and the RING protein Rbx1 (69). Recently, it was shown that degradation of p53 is significantly impaired in a Cullin5 knockdown cell line (43) . On the basis of these data, we examined ATRX protein levels in infected Cullin5 negative and control H1299 cells [ Figure 7A ; (37) ]. Reduction of Daxx and Mre11 is dependent on Cullin5, as no decrease was observed in Cullin5 negative H1299 cells infected with wild-type ( Figure 7A, lane 6 ). These data demonstrate that similar to known targets of the Ad5 E3 ubiquitin ligase, ATRX is degraded via a Cullin5-dependent proteasomal pathway, which requires E1B-55K and E4orf6. In addition to Cullin5, E4orf6 was previously shown to assemble with cellular proteins Rbx1 and Elongins B/C to form the E3 ubiquitin ligase to degrade cellular factors in presence of E1B-55K (69). Moreover, E4orf6 was shown to bind Elongins B and C via two conserved BC box motifs. Next, we examined ATRX protein levels in H1299 cells, infected with a E4orf6 virus mutant carrying point mutations in this BC Box, abrogating the formation of the Ad5 ubiquitin ligase complex. Our results strongly implicate that activity of the E1B-55K/E4orf6 ligase complex is essential to reduce ATRX protein concentration ( Figure 7B , lane 5). Consistent with previous publications we observed, Daxx reduction, but no degradation, of Mre11 during lytic infection with the BC-box virus mutant H5pm4139 ( Figure 7B, lane 5) . This confirms the fact that formation and ligase activity of the E1B-55K/ E4orf6 complex is essential for ATRX degradation via host cell proteasomes.
To further interconnect our conclusions, we monitored ATRX protein levels in the soluble and chromatin-rich fraction of Ad5-infected cells. Unexpectedly, Daxx and ATRX were reproducibly declined during wt (H5pg4100) lytic infection in the chromatin fraction, although only a minor amount of the viral proteins could be detected in this fraction ( Figure 7C ). In contrast, we observed no reduction of the cellular chromatin-associated factors in infected cells lacking E1B-55K (H5pm4149; Figure 7C , lanes 3 and 6).
Ad-mediated inactivation of Daxx/ATRX functions affects H3.3 association with Ad promoters and chromatin condensation
Daxx is involved in deposition of cellular histone variant H3.3 on actively transcribed genes. Recent reports showed that Daxx either alone or in complex with ATRX actively assembles H3.3-containing nucleosomes (19, 20, 70) . In line with this, Ad DNA was recently observed to preferentially associate with H3.3 (71), indicating that chromatinization by a replication-independent mechanism may play a so far unknown role during Ad life cycle. To enrich the novelty of our findings and giving the fact that we observed Daxx/ ATRX complex mainly degraded in the chromatin fraction of the host cell, we experimentally assessed the effects of Ad5 wt infection on Daxx/ATRX-dependent H3.3 recruitment on viral promoters (Figure 8 ). ChIP analysis showed that H3.3 was found to be complexed with viral promoters (E1A, E1B) 24 h after infection of Hep parental cells (5 fluorescent forming units (FFU)/ cell). Although using infected cells, treated with higher amounts of virus particles (100 FFU/cell), inducing Daxx and ATRX reduction, H3.3 association at viral promoters was significantly lost [promoter binding beyond 1%; (72) ]. To determine whether this observation could be linked to efficient Ad-dependent Daxx/ATRX proteasomal degradation, we examined H3.3 loss from Ad promoters in infected HepaRG knockdown and control cells. We observed that the majority of H3.3 was lost from the viral DNA, although cells were treated with a very low multiplicity of infection (moi) of 5 FFU/cell (Hep shDaxx cells; Hep shATRX cells; Figure 8A ). We observed the same result in infected Hep Daxx PAH cells in the absence of a functional Daxx/ATRX complex ( Figure 8A ). To validate functional restriction of the Daxx/ATRX complex via Ad-dependent proteasomal degradation, we monitored Daxx and ATRX protein levels in infected HepaRG cells used for our ChIP analysis. Daxx and ATRX protein concentrations reproducibly declined during Ad wt (H5pg4100) infection with a moi of 100 FFU/cell after 24 h ( Figure 8B , and proteins were separated by SDS-PAGE and subjected to immunoblotting using mouse MAb 2A6 (E1B-55K), mouse MAb RSA3 (E4orf6), Daxx-and Mre11-specific rabbit Ab and ATRX-specific mouse MAb clone 39F. b-actin was included as a loading control. (C) H1299 cells were infected with wild-type (H5pg4100) and E1B minus mutant virus (H5pm4149) at moi of 50 FFU per cell. Then, 48 h. p. i., total cell extracts were prepared after fractionation of soluble and chromatin fractions as described recently (60) . Proteins were separated by SDS-PAGE and subjected to immunoblotting using Mre11-specific rabbit Ab, Daxx-specific rabbit Ab and ATRX-specific mouse MAb clone 39F, mouse MAb 2A6 (E1B-55K) and mouse MAb RSA3 (E4orf6). To gain further insight into the ability of Ad to modulate chromatin structure, we performed MNase chromatin sensitivity assays to directly evaluate any consequence of proteasomal Daxx/ ATRX reduction due to E1B-55K and E4orf6 expression on bulk cellular chromatin. We analysed MNase sensitivity of chromatin from Ad-infected HepaRG parental (100 FFU/cell), uninfected HepaRG parental and shDaxx cells ( Figure 9 ) and observed that Daxx reduction in Hep shDaxx and Hep parental (100 FFU/cell) resulted in a greater sensitivity of the chromatin to MNase digestion compared with uninfected control cells (Hep parental mock). This is evident from the increase in mono-, di-and tri-nucleosomes after equivalent lengths of MNase treatment (1, 2, 5 and 7.5 min; Figure 9 ) and by the reduced amount of undigested chromatin in the absence of Daxx (Hep shDaxx mock and Hep parental, 100 FFU/cell). In contrast to this, presence of Daxx (Hep parental mock) promoted reduced sensitivity of the chromatin to MNase digestion ( Figure 9 ). Therefore, it is likely that Daxx reduction by either siRNA-mediated techniques or productive Ad5 infection results in a less condensed and accessible chromatin architecture. These findings demonstrate that functional Daxx/ATRX cooperation is important for chromatin remodelling, and depletion of these cellular factors results in a less condensed chromatin state and enhanced viral gene expression.
DISCUSSION
Chromatin structure is regulated by multiprotein complexes that either covalently modify histone tails or remodel nucleosomes in an ATP-dependent manner (73) . Together, these complexes cooperate to dynamically regulate chromatin structure. To date, considerable progress has been made in studying ATP-dependent chromatin remodelling complexes, mediating essential steps in regulating eukaryotic gene expression. These chromatinassociated complexes are highly conserved during evolution and often recruited to targets by sequence-specific transcription factors binding to certain promoters (74) . SWI/SNF complexes use the energy of ATP-hydrolysis to alter histone/DNA contacts, leading to changes in chromatin conformation depending on acetylation of the N-terminal core histone tails (see Figure 6B ). Although the basic mechanism is still not fully understood, obviously DNA viruses have acquired various strategies to interfere with chromatin remodelling, modulate histone/ DNA contacts and establish lytic or latent infection. Ad viruses infect a wide range of cell types, promoting cell cycle progression and simultaneously blocking apoptosis and growth arrest (23, (75) (76) (77) . Consequently, manipulation of host cell homeostasis is required for Ad productive infection. Considering the fundamental importance of chromatin formation in regulating gene expression in host cells, it remains unclear whether Ad DNA is chromatinized and whether Ad transcription is regulated by cellular chromatin remodelling complexes.
However, recent findings illustrate that Ad genomes are highly condensed by viral core proteins in the capsid (78) (79) (80) . This core/DNA complex enters the host cell nucleus and decondenses before early viral gene transcription (72) . Although the molecular details are still unclear, dynamic regulation of chromatin condensation suggests involvement of cellular chromatin remodelling complexes. Our findings illustrate that cellular Daxx/ATRX chromatin remodelling complexes associate with Ad genomes and promotes active viral gene transcription during the immediate early phase of Ad infection ( Figure 3B ).
Daxx is reportedly involved in depositing cellular histone variant H3.3 on actively transcribed genes (19, 20, 70) . In line with this, Ad DNA was recently observed to preferentially associate with H3.3 (71), indicating that chromatinization by a replicationindependent mechanism may play a so far unknown role during the Ad life cycle. Interestingly, H3.3 was also found to be complexed with 'herpes simplex virus type 1' DNA during the early phase of infection (81) . Altogether, H3.3 deposition on incoming genomes of DNA viruses suggests a common mechanism for histone deposition in promoting efficient viral gene expression (71, 81) . Daxx's impact on chromatinization via H3.3 deposition is consistent with our findings of functional Daxx-ATRX cooperation within a SWI/SNF chromatin remodelling complex ( Figure 9 , summarized in Figure 10) .
Recent results together with our observations demonstrate the importance of a functional interplay between two types of Daxx chromatin remodelling activities on efficient Ad gene expression. As it is speculated that Ad DNA is chromatinized, epigenetic regulation may be as important for expression of Ad-encoded genes as for expression of host cell genes. Komatsu et al. (72) showed an increase over time in acetylated H3 association at all Ad promoters tested.
In agreement, we show here that Ad promoters are affected by Daxx/ATRX-mediated transcriptional repression. As acetylated histones are associated with actively transcribed genes, this suggests that inhibiting Daxx/ ATRX recruitment of HDAC to these promoters changes the epigenetic status for optimal viral gene expression. Thus, E1B-55K/E4orf6-dependent restriction of Daxx/ATRX functional complexes may be relevant for the virus to evade antiviral host cell measures to repress viral gene expression. Indeed, recent reports demonstrate that during Ad vector studies, viral chromatin was preferentially associated with deacetylated histones, markers of transcriptionally inactive chromatin (71, 84) . These observations clearly illustrate the importance of epigenetic regulation of Ad DNA at the chromatin level by expressing early viral proteins that counteract chromatin remodelling functions of the cell.
To ensure efficient viral gene expression, it seems reasonable that Daxx and ATRX are eliminated during Ad5 infection, or their repressive capacity is limited by E1B-55K interaction, Daxx/ATRX protein degradation, or induction of posttranslational modifications. However, our findings illustrate that Ad5-mediated degradation discriminates between E1B-55K-(Daxx) and E1B-55K/E4orf6 (ATRX)-dependent pathways. Nevertheless, it is still unclear how and why Ad5 differentially regulates Daxx and ATRX proteolysis. Furthermore, it remains elusive whether the proposed mechanism is a kinetic process owing to expression or post-translational modification of viral proteins E1B-55K and E4orf6 early during Ad5 infection.
Chromatin modifying complexes have also been implicated in human cancer development. There is growing evidence for a correlation between chromatin modifiers and tumour suppression, especially demonstrated for SWI/SNF complexes, which comprise several subunits displaying tumour suppressor activity (73) . Functional disruption of SWI/SNF complexes may induce a state of epigenetic instability, resulting in altered chromatin structure that affects gene expression and interferes with differentiation processes. These epigenetic changes may be closely linked to genomic instability and predispose to oncogenic transformation. In this context, our recent studies already provide evidence that efficient adenoviral transformation requires E1B-55K-mediated degradation of Daxx (61) . In accordance to our current study, we assume that this Ad oncoprotein contributes to cell transformation by modulating Daxx-dependent pathways and consequently through disrupting SWI/SNF chromatin remodelling functions. This is a particularly interesting concept, given the oncogenic capabilities of certain adenoviral oncogenes (e.g. E1A, E1B-55K, E4orf6), which we have partially shown to cooperate with either Daxx and/or ATRX. Therefore, elucidating the mechanisms of these cellular regulators, as subunits of cellular SWI/SNF complexes, will help to define the role of chromatin remodelling in both Ad5 transcriptional regulation and adenoviral transformation of primary cells. These findings might also help to identify novel therapeutic approaches to modern cancer therapy.
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